Company

Open Orphan plc

Headquarters: London, United Kingdom

Employees: 179

CEO: Dr. Yamin Mohammed Khan Ph.D.

LSE: ORPH -3.83%

Market Cap

£19.96 Billion

GBP as of Jan. 1, 2024

US$25.41 Billion

history Market Cap History

Open Orphan plc market capitalization over time

Evolution of Open Orphan plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Open Orphan plc

Detailed Description

Open Orphan plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to Big Pharma, biotech, government, and public health organizations. The company has a portfolio of eight human challenge study models for conditions, such as RSV, flu, asthma and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company is headquartered in London, the United Kingdom.

Top 1-year algo backtest: +240.10%

$10,000 in February 2023 would now be $34,010 by following it 5 minutes per day at market close.

How much did you gain in the last 12 months?

Stocks & Indices

Open Orphan plc has the following listings and related stock indices.


Stock: LSE: ORPH wb_incandescent

Stock: FSX: CRO wb_incandescent

Stock: ISE: ORPH wb_incandescent

Details

Headquarters:

150 Minories

4th Floor

London, EC3N 1LS

United Kingdom

Phone: 44 20 7756 1300